These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 31650163

  • 1. Downregulation of MANCR inhibits cancer cell proliferation in mantle cell lymphoma possibly by interacting with RUNX2.
    Wen S, Zeng M, Li Y, Hu X, Li S, Liang X, Zhu L, Yang S.
    Acta Biochim Biophys Sin (Shanghai); 2019 Nov 18; 51(11):1142-1147. PubMed ID: 31650163
    [Abstract] [Full Text] [Related]

  • 2. LncRNA E2F-Mediated Cell Proliferation Enhancing lncRNA Regulates Cancer Cell Behaviors and Affects Prognosis of Gastric Cancer.
    Fu J, Zhao W, Guo D, Li Z.
    Dig Dis Sci; 2020 May 18; 65(5):1348-1354. PubMed ID: 31584135
    [Abstract] [Full Text] [Related]

  • 3. Mitotically-Associated lncRNA (MANCR) Affects Genomic Stability and Cell Division in Aggressive Breast Cancer.
    Tracy KM, Tye CE, Ghule PN, Malaby HLH, Stumpff J, Stein JL, Stein GS, Lian JB.
    Mol Cancer Res; 2018 Apr 18; 16(4):587-598. PubMed ID: 29378907
    [Abstract] [Full Text] [Related]

  • 4. Mitotically-associated long non-coding RNA promotes cancer cell proliferation in hepatocellular carcinoma by downregulating miR-122a.
    Zhang X, Li H, Mao M, Wang X, Zheng J, Yang S.
    Oncol Lett; 2019 Dec 18; 18(6):6237-6242. PubMed ID: 31788100
    [Abstract] [Full Text] [Related]

  • 5. LINC01638 silencing inhibits cancer cell proliferation in colorectal adenocarcinoma through interaction with RUNX2.
    Zhuo W, Hu D, Chen X, Zhang T.
    Mol Med Rep; 2019 Jun 18; 19(6):5275-5280. PubMed ID: 31059049
    [Abstract] [Full Text] [Related]

  • 6. LncRNA LUADT1 is Upregulated in Mantle Cell Lymphoma and Modulates TRIM11 by Sponging miR-24-3p to Inhibit Cell Apoptosis.
    Dong L, Zhang H, Zan T, Han J, Xue Q, Sun Y.
    Crit Rev Eukaryot Gene Expr; 2021 Jun 18; 31(5):33-40. PubMed ID: 34591388
    [Abstract] [Full Text] [Related]

  • 7. lncRNA FOXP4‑AS1 predicts poor prognosis and accelerates the progression of mantle cell lymphoma through the miR‑423‑5p/NACC1 pathway.
    Tao HF, Shen JX, Hou ZW, Chen SY, Su YZ, Fang JL.
    Oncol Rep; 2021 Feb 18; 45(2):469-480. PubMed ID: 33416160
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-506 inhibits the proliferation and invasion of mantle cell lymphoma cells by targeting B7H3.
    Zhu XW, Wang J, Zhu MX, Wang YF, Yang SY, Ke XY.
    Biochem Biophys Res Commun; 2019 Jan 22; 508(4):1067-1073. PubMed ID: 30553455
    [Abstract] [Full Text] [Related]

  • 9. LINK-A lncRNA Promotes Proliferation and Inhibits Apoptosis of Mantle Cell Lymphoma Cell by Upregulating Survivin.
    Zhang Y, Lu P, Du H, Zhang L.
    Med Sci Monit; 2019 Jan 12; 25():365-370. PubMed ID: 30636001
    [Abstract] [Full Text] [Related]

  • 10. Upregulation of MANCR predicts poor survival in patients with gastric cancer.
    Yao L, Yan J, Gan L, Huang S, Cheng F, Fang N.
    Oncol Lett; 2019 Dec 12; 18(6):6801-6806. PubMed ID: 31807188
    [Abstract] [Full Text] [Related]

  • 11. LncRNA MANCR positively affects the malignant progression of lung adenocarcinoma.
    Liu C, Li H, Li X, Zhao X, Zhang X.
    BMC Pulm Med; 2021 Aug 21; 21(1):272. PubMed ID: 34418982
    [Abstract] [Full Text] [Related]

  • 12. MANCR lncRNA Modulates Cell-Cycle Progression and Metastasis by Cis-Regulation of Nuclear Rho-GEF.
    Singh DK, Cong Z, Song YJ, Liu M, Chaudhary R, Liu D, Wang Y, Prasanth R, K C R, Lizarazo S, Akhnoukh M, Gholamalamdari O, Moitra A, Jenkins LM, Bhargava R, Nelson ER, Van Bortle K, Prasanth SG, Prasanth KV.
    Mol Cell Biol; 2024 Aug 21; 44(9):372-390. PubMed ID: 39133105
    [Abstract] [Full Text] [Related]

  • 13. LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2.
    Wang X, Sehgal L, Jain N, Khashab T, Mathur R, Samaniego F.
    J Transl Med; 2016 Dec 20; 14(1):346. PubMed ID: 27998273
    [Abstract] [Full Text] [Related]

  • 14. The Signal Transducer and Activator of Transcription 5B (STAT5B) Gene Promotes Proliferation and Drug Resistance of Human Mantle Cell Lymphoma Cells by Activating the Akt Signaling Pathway.
    Zhang W, Liang X, Gong Y, Xiao C, Guo B, Yang T.
    Med Sci Monit; 2019 Apr 09; 25():2599-2608. PubMed ID: 30964854
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of lncRNA GATA6-AS inhibits cancer cell proliferation in mantle cell lymphoma by downregulating GLUT1.
    Fan Z, Wang X, Li P, Mei C, Zhang M, Zhao C.
    Oncol Lett; 2019 Sep 09; 18(3):2443-2447. PubMed ID: 31402946
    [Abstract] [Full Text] [Related]

  • 16. Bromodomain Proteins Epigenetically Regulate the Mitotically Associated lncRNA MANCR in Triple Negative Breast Cancer Cells.
    Tracy KM, Prior S, Trowbridge WT, Boyd JR, Ghule PN, Frietze S, Stein JL, Stein GS, Lian JB.
    Crit Rev Eukaryot Gene Expr; 2024 Sep 09; 34(2):61-71. PubMed ID: 38073442
    [Abstract] [Full Text] [Related]

  • 17. Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma.
    Teshima K, Nara M, Watanabe A, Ito M, Ikeda S, Hatano Y, Oshima K, Seto M, Sawada K, Tagawa H.
    Oncogene; 2014 Apr 24; 33(17):2191-203. PubMed ID: 23686310
    [Abstract] [Full Text] [Related]

  • 18. Targeting CERS6-AS1/FGFR1 axis as synthetic vulnerability to constrain stromal cells supported proliferation in Mantle cell lymphoma.
    Jindal U, Mamgain M, Nath UK, Sharma I, Pant B, Sharma A, Gupta A, Rahman K, Yadav S, Singh MP, Mishra S, Chaturvedi CP, Courty J, Singh N, Gupta S, Kumar S, Verma SP, Mallick S, Gogia A, Raghav S, Sarkar J, Srivastava KR, Datta D, Jain N.
    Leukemia; 2024 Oct 24; 38(10):2196-2209. PubMed ID: 39003397
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-154 as a prognostic factor in bladder cancer inhibits cellular malignancy by targeting RSF1 and RUNX2.
    Zhao X, Ji Z, Xie Y, Liu G, Li H.
    Oncol Rep; 2017 Nov 24; 38(5):2727-2734. PubMed ID: 29048677
    [Abstract] [Full Text] [Related]

  • 20. MANCR drives esophageal carcinoma progression by targeting PDE4D.
    Fan J, Wang F.
    J BUON; 2021 Nov 24; 26(4):1517-1522. PubMed ID: 34565013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.